Results 461-480 of 1,172,832 for in 'Dáil debates' OR (speaker:John Dolan OR speaker:Denis Naughten OR speaker:Barry Cowen OR speaker:Malcolm Noonan OR speaker:Paul McAuliffe OR speaker:Richard Bruton OR speaker:Darragh O'Brien OR speaker:Martin Browne OR speaker:Jennifer Whitmore OR speaker:Pat Buckley OR speaker:Duncan Smith OR speaker:Donnchadh Ó Laoghaire OR speaker:Christopher O'Sullivan OR speaker:Matt Carthy OR speaker:Marian Harkin OR speaker:Holly Cairns OR speaker:Catherine Martin OR speaker:Pippa Hackett OR speaker:Colm Burke OR speaker:Peadar Tóibín OR speaker:Robert Troy OR speaker:Richard Bruton6 OR speaker:Marc MacSharry OR speaker:James Lawless OR speaker:Roderic O'Gorman OR speaker:Alan Dillon OR speaker:Charlie McConalogue OR speaker:Thomas Gould OR speaker:Mattie McGrath OR speaker:Michael McGrath OR speaker:Paul Murphy OR speaker:Patrick O'Donovan OR speaker:Michael Collins OR speaker:Róisín Shortall OR speaker:Gary Gannon OR speaker:Verona Murphy OR speaker:Dessie Ellis OR speaker:Pearse Doherty OR speaker:John Brady OR speaker:Rose Conway-Walsh OR speaker:Catherine Murphy OR speaker:Seán Sherlock OR speaker:Mary Lou McDonald OR speaker:Paul Donnelly OR speaker:Louise O'Reilly OR speaker:Maurice Quinlivan) in 'Committee meetings'

Committee on Drugs Use: Family and Community: Discussion (24 Oct 2024)

Paul McAuliffe: In theory, the UBU project is for general youth work and the youth justice system is for more targeted youth work. On young people being referred to services through the Garda referral process, what is Mr. Ducque's experience of criminal association with addiction or involvement in the sale or distribution of drugs? How does that get in the way of working with young people? Does it get in...

Committee on Drugs Use: Family and Community: Discussion (24 Oct 2024)

Paul McAuliffe: They are picking up too many charges.

Committee on Drugs Use: Family and Community: Discussion (24 Oct 2024)

Paul McAuliffe: It is an opportunity to engage.

Committee on Drugs Use: Family and Community: Discussion (24 Oct 2024)

Louise O'Reilly: I thank the witnesses. I am substituting for my colleague an Teachta Thomas Gould. My first question, and this will probably will not surprise Mr. Perth, is for Connect 4. I was able to watch a bit on screen but also read the submissions. I was struck when the perception of self-sabotage of the area was spoken about. Perhaps Mr. Perth could talk about how young people's perception of...

Committee on Drugs Use: Family and Community: Discussion (24 Oct 2024)

Louise O'Reilly: I thank Mr. Perth for that. For the broader witnesses, my understanding is that the committee has agreed that public consumption of drugs cannot be allowed to increase, as we have heard from other jurisdictions that this has huge impacts when they decriminalise drugs. How can we control public consumption without further stigmatising the people the witnesses are working with? How can those...

Committee on Drugs Use: Family and Community: Discussion (24 Oct 2024)

Louise O'Reilly: I agree.

Committee on Drugs Use: Family and Community: Discussion (24 Oct 2024)

Louise O'Reilly: It would be overwhelmed.

Committee on Drugs Use: Family and Community: Discussion (24 Oct 2024)

Louise O'Reilly: Specifically regarding public consumption and the way that can be managed, my understanding is the committee had agreed that an increase in public consumption should not necessarily be a by-product. How can that be done without further stigmatisation, however? We spoke about stigma and trauma. How can that be done without heaping further stigma on communities that do not need it and cannot...

Public Accounts Committee: Financial Statements 2023: Health Service Executive (24 Oct 2024)

Paul McAuliffe: I acknowledge the Cathaoirleach's new position. I have no doubt but that she will continue the good work of the previous Chair in chairing this committee and doing it in a cross-party way. Our work in this committee is very important, but so is the way we do our work. It is important and different from other committees. I acknowledge this point. I thank Mr. Gloster and all the team for...

Public Accounts Committee: Financial Statements 2023: Health Service Executive (24 Oct 2024)

Paul McAuliffe: I saw a figure regarding the outpatient waiting lists having been reduced by 50,000 people. Mr. Gloster is saying this is a real reduction rather than a validation exercise.

Public Accounts Committee: Financial Statements 2023: Health Service Executive (24 Oct 2024)

Paul McAuliffe: Will Mr. Gloster repeat that figure?

Public Accounts Committee: Financial Statements 2023: Health Service Executive (24 Oct 2024)

Paul McAuliffe: I accept that point. The experience just shone a light on the outpatients waiting list for me.

Public Accounts Committee: Financial Statements 2023: Health Service Executive (24 Oct 2024)

Paul McAuliffe: We do not know, but this may be the last or the second last meeting of this committee. It will certainly be the last meeting during this Dáil when Mr. Gloster will be before us anyway.

Public Accounts Committee: Financial Statements 2023: Health Service Executive (24 Oct 2024)

Paul McAuliffe: I am very much cognisant of the volume of money associated with this hearing. We are talking about €23.5 billion. Many Government Departments could be folded into that figure. In 2019, the figure was €16 billion. Essentially, there has been a 46% increase in the funding of the HSE over the past four years, that is, the lifetime of this Government. In 60 seconds, can Mr....

Public Accounts Committee: Financial Statements 2023: Health Service Executive (24 Oct 2024)

Paul McAuliffe: I would love to explore that point more but I just do not have the time. Turning to the non-compliant procurement, this is the first thing we look at in this committee. The HSE estimated that the total expenditure on goods and services subject to procurement rules was €4.2 billion. Again, this amount is multiples of an entire Government Department in some cases. The idea that...

Public Accounts Committee: Financial Statements 2023: Health Service Executive (24 Oct 2024)

Paul McAuliffe: When the HSE did the self-assessed audit, there was a very significant percentage of either non-co-operation or where you could not identify the purchaser. The figure of 12% actually could be higher.

Public Accounts Committee: Financial Statements 2023: Health Service Executive (24 Oct 2024)

Paul McAuliffe: Just to return to that point, Mr. Mulvany is saying the figure of 12% does include the 13% of invoices within the scope of the exercise where either the manager responsible could not be identified or where the manager failed to respond to the exercise. He is saying that 13% is deemed non-compliant and is included in the 12%.

Public Accounts Committee: Financial Statements 2023: Health Service Executive (24 Oct 2024)

Paul McAuliffe: Will the C and AG confirm that?